Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials
M Bazzi, A Badros - Cancer Biology & Therapy, 2010 - Taylor & Francis
Multiple Myeloma is a molecularly heterogeneous disease with a high degree of genomic
instability in which specific genetic changes can be linked to clinical presentation and …
instability in which specific genetic changes can be linked to clinical presentation and …
Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.
M Bazzi, A Badros - Cancer Biology & Therapy, 2010 - europepmc.org
Multiple Myeloma is a molecularly heterogeneous disease with a high degree of genomic
instability in which specific genetic changes can be linked to clinical presentation and …
instability in which specific genetic changes can be linked to clinical presentation and …
Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials
M Bazzi, A Badros - Cancer biology & therapy, 2010 - pubmed.ncbi.nlm.nih.gov
Multiple Myeloma is a molecularly heterogeneous disease with a high degree of genomic
instability in which specific genetic changes can be linked to clinical presentation and …
instability in which specific genetic changes can be linked to clinical presentation and …